8-(4-CHLOROPHENYLTHIO)GUANOSINE 3',5'-CYCLIC MONOPHOSPHATE SODIUM SALT structure
|
Common Name | 8-(4-CHLOROPHENYLTHIO)GUANOSINE 3',5'-CYCLIC MONOPHOSPHATE SODIUM SALT | ||
|---|---|---|---|---|
| CAS Number | 51239-26-0 | Molecular Weight | 509.79300 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H14ClN5NaO7PS | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
| Name | 8-(4-Chlorophenylthio)-guanosine 3′,5′-cyclic monophosphate sodium salt |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C16H14ClN5NaO7PS |
|---|---|
| Molecular Weight | 509.79300 |
| Exact Mass | 508.99400 |
| PSA | 212.75000 |
| LogP | 2.29990 |
| RIDADR | NONH for all modes of transport |
|---|---|
| WGK Germany | 3 |
|
Contribution of nitric oxide-dependent guanylate cyclase and reactive oxygen species signaling pathways to desensitization of μ-opioid receptors in the rat locus coeruleus.
Neuropharmacology 99 , 422-31, (2015) Nitric oxide (NO) is involved in desensitization of μ-opioid receptors (MOR). We used extracellular recordings in vitro to unmask the NO-dependent pathways involved in MOR desensitization in the rat l... |
|
|
Adenosine modulates light responses of rat retinal ganglion cell photoreceptors througha cAMP-mediated pathway.
J. Physiol. 592(Pt 19) , 4201-20, (2014) Adenosine is an established neuromodulator in the mammalian retina, with A1 adenosine receptors being especially prevalent in the innermost ganglion cell layer. Activation of A1 receptors causes inhib... |
|
|
Phosphodiesterase 5 inhibition ameliorates angiontensin II-induced podocyte dysmotility via the protein kinase G-mediated downregulation of TRPC6 activity.
Am. J. Physiol. Renal Physiol. 306(12) , F1442-50, (2014) The emerging role of the transient receptor potential cation channel isotype 6 (TRPC6) as a central contributor to various pathological processes affecting podocytes has generated interest in the deve... |
| sodium,9-[(4aR,6R,7R,7aS)-7-hydroxy-2-oxido-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-2-amino-8-(4-chlorophenyl)sulfanyl-3H-purin-6-one |
| 8-pCPT-cGMP |
| MFCD00674888 |